AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 137 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,193,079 | +1.5% | 970,702 | +76.5% | 0.00% | 0.0% |
| Q2 2023 | $6,099,578 | -28.1% | 550,007 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $8,488,750 | +306132.0% | 552,984 | +342.7% | 0.00% | – |
| Q4 2022 | $2,772 | -99.8% | 124,918 | +12.4% | 0.00% | – |
| Q3 2022 | $1,814,000 | -1.4% | 111,121 | -12.2% | 0.00% | – |
| Q2 2022 | $1,840,000 | -1.5% | 126,582 | +25.2% | 0.00% | – |
| Q1 2022 | $1,868,000 | -29.4% | 101,115 | -9.2% | 0.00% | – |
| Q4 2021 | $2,647,000 | +296.3% | 111,371 | +310.9% | 0.00% | – |
| Q3 2021 | $668,000 | +56.4% | 27,105 | +56.9% | 0.00% | – |
| Q2 2021 | $427,000 | +29.4% | 17,278 | +14.1% | 0.00% | – |
| Q1 2021 | $330,000 | +71.9% | 15,139 | +101.6% | 0.00% | – |
| Q4 2020 | $192,000 | +6.7% | 7,509 | +20.4% | 0.00% | – |
| Q3 2020 | $180,000 | – | 6,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |